Peptic Ulcer Global Market Report 2025

Description

An open sore or raw area in the stomach lining or intestine is known as a peptic ulcer. It is primarily a result of the erosion of the protective lining of the stomach or the upper part of the small intestine, known as the duodenum. Common symptoms of peptic ulcers include upper abdominal pain or discomfort and symptoms of acid reflux, such as heartburn, sometimes accompanied by nausea.

The primary disease indications consist of gastritis, gastric ulcers, duodenal ulcers, and gastroesophageal reflux disease (GERD). Gastritis is a medical condition characterized by inflammation, irritation, or erosion of the stomach lining. The typical approach to treating gastritis involves medications such as proton pump inhibitors and lifestyle adjustments. The drugs utilized include proton pump inhibitors (PPI), H2 antagonists, antibiotics, and other pharmaceuticals, which are distributed through various channels such as hospital pharmacies, private clinics, drug stores, retail pharmacies, and e-commerce.

The peptic ulcer market research report is one of a series of new reports from The Business Research Company that provides peptic ulcer market statistics, including peptic ulcer industry global market size, regional shares, competitors with a peptic ulcer market share, detailed peptic ulcer market segments, market trends and opportunities, and any further data you may need to thrive in the peptic ulcer industry. This peptic ulcer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The peptic ulcer market size has grown steadily in recent years. It will grow from $4.1 billion in 2024 to $4.24 billion in 2025 at a compound annual growth rate (CAGR) of 3.5%. The growth in the historic period can be attributed to increased prevalence of helicobacter pylori infection, rising use of nonsteroidal anti-inflammatory drugs (NSAIDs), changing lifestyles and dietary habits, awareness campaigns and educational initiatives, focus on stress management.

The peptic ulcer market size is expected to see steady growth in the next few years. It will grow to $4.91 billion in 2029 at a compound annual growth rate (CAGR) of 3.7%. The growth in the forecast period can be attributed to emerging therapies and treatment modalities, increasing geriatric population, integration of precision medicine, preventive measures and health promotion, continued research and clinical trials. Major trends in the forecast period include digital health solutions, advancements in treatment modalities, increasing prevalence of helicobacter pylori infection, integration of diagnostic imaging technologies, increasing use of combination therapies.

The rising incidence of obesity is anticipated to drive the growth of the peptic ulcer market in the future. Obesity is a medical condition marked by an excessive accumulation of body fat, typically defined as having a body mass index (BMI) of 30 or higher. It can arise from a combination of genetic, environmental, and lifestyle factors, including poor dietary habits and insufficient physical activity. Obesity leads to an overproduction of stomach acid, compromises the protective mucosal lining of the stomach, and contributes to the development of peptic ulcers. Additionally, excess weight appears to increase inflammation in the gut, which can further facilitate the emergence of peptic ulcers. For example, in September 2024, the Centers for Disease Control and Prevention, a U.S.-based public health agency, reported that between August 2021 and August 2023, the prevalence of obesity among adults was 40.3%, with rates of 39.2% in men and 41.3% in women. Thus, the increasing prevalence of obesity is driving the expansion of the peptic ulcer market.

The escalating rates of smoking are expected to fuel the peptic ulcer market's growth in the foreseeable future. Smoking, the inhalation of vapors from burning plant-based products such as tobacco or marijuana, is a well-established contributor to peptic ulcer disease. Smoking harms the stomach and duodenal linings, reduces blood supply to the stomach, and increases stomach acid production, elevating the incidence of peptic ulcers. For example, data from Quit Victoria in June 2023 highlighted a threefold increase in current cigarette smoking among 14-17-year-olds over four years, reaching 6.7% in 2022. Consequently, the rising smoking rates serve as a driving factor for the peptic ulcer market.

Companies in the peptic ulcer market are focusing on developing innovative products and solutions, obtaining approval from federal agencies to secure a competitive advantage. The development of drugs is essential for managing and treating peptic ulcers, as it helps with symptom management, healing, preventing complications, and addressing the underlying issues. For example, in April 2023, Akums Drugs and Pharmaceutical Ltd., a pharmaceutical formulations and active pharmaceutical ingredients (APIs) company based in India, launched its new formulation, the Combikit, which combines Amoxicillin, Clarithromycin, and Esomeprazole. This Combikit has been approved by the Central Drugs Standard Control Organisation (CDSCO) for the treatment of duodenal ulcers associated with Helicobacter pylori (H. pylori) and for the eradication of H. pylori in patients with either active or healed peptic ulcers. The therapy targeting H. pylori has shown effectiveness in reducing the risk of ulcer recurrence, providing significant advantages to patients. H. pylori is a common infection in India and is linked to the development of gastritis and peptic ulcers.

In July 2022, Juvise Pharmaceuticals, a France-based pharmaceutical company, acquired the global commercial rights to Pylera from AbbVie Inc. for $408 million (€400 million). Pylera, an antimicrobial tri-therapy, targets peptic ulcers caused by Helicobacter pylori (H. pylori) infection. This acquisition is expected to facilitate Juvise Pharmaceuticals' expansion of its gastro-intestinal medicine product portfolio, serving as a strategic addition for geographic expansion. AbbVie Inc., a U.S.-based pharmaceutical company, specializes in providing various medications for diverse conditions, including peptic ulcers.

Major companies operating in the peptic ulcer market report are Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., CSL Limited, Boehringer Ingelheim International GmbH, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Zydus Lifesciences, Lupin Limited, Livzon Pharmaceutical Group Inc., Yuhan Corporation, Torrent Pharmaceuticals Ltd., Daewoong Pharmaceutical Co. Ltd., Ilyang Pharmaceutical Co, Jiangsu Carephar Pharmaceutical Co Ltd.

North America was the largest region in the peptic ulcer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptic ulcer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the peptic ulcer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The peptic ulcer market consists of revenues earned by entities by providing treatment services related to peptic ulcer such as surgeries, endoscopy, blood tests, and physical exams. The market value includes the value of related goods sold by the service provider or included within the service offering. The peptic ulcer market also includes sales of acid blockers, cytoprotective agents, bismuth subsalicylate, and mastic powder. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Peptic Ulcer Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on peptic ulcer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for peptic ulcer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The peptic ulcer market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Disease Indication: Gastritis; Gastric Ulcer; Duodenal Ulcer; Gastroesophageal Reflux Disease (GERD)
2) By Drug Type: Proton Pump Inhibitors (PPI); H2 Antagonists; Antibiotics; Other Drugs
3) By Distribution Channel: Hospital Pharmacies; Private Clinics; Drug Store; Retail Pharmacies; E-Commerce
Subsegments:
1) By Gastritis: Acute Gastritis; Chronic Gastritis
2) By Gastric Ulcer: Acute Gastric Ulcer; Chronic Gastric Ulcer
3) By Duodenal Ulcer: Acute Duodenal Ulcer; Chronic Duodenal Ulcer
4) By Gastroesophageal Reflux Disease (GERD): Non-Erosive GERD; Erosive GERD
Companies Mentioned: Johnson & Johnson; Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Novartis AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r28713

1. Executive Summary

2. Peptic Ulcer Market Characteristics

3. Peptic Ulcer Market Trends And Strategies

4. Peptic Ulcer Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Peptic Ulcer Growth Analysis And Strategic Analysis Framework

5.1. Global Peptic Ulcer PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Peptic Ulcer Market Growth Rate Analysis
5.4. Global Peptic Ulcer Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Peptic Ulcer Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Peptic Ulcer Total Addressable Market (TAM)

6. Peptic Ulcer Market Segmentation

6.1. Global Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gastritis
Gastric Ulcer
Duodenal Ulcer
Gastroesophageal Reflux Disease (GERD)
6.2. Global Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Proton Pump Inhibitors (PPI)
H2 Antagonists
Antibiotics
Other Drugs
6.3. Global Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Private Clinics
Drug Store
Retail Pharmacies
E-Commerce
6.4. Global Peptic Ulcer Market, Sub-Segmentation Of Gastritis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Acute Gastritis
Chronic Gastritis
6.5. Global Peptic Ulcer Market, Sub-Segmentation Of Gastric Ulcer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Acute Gastric Ulcer
Chronic Gastric Ulcer
6.6. Global Peptic Ulcer Market, Sub-Segmentation Of Duodenal Ulcer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Acute Duodenal Ulcer
Chronic Duodenal Ulcer
6.7. Global Peptic Ulcer Market, Sub-Segmentation Of Gastroesophageal Reflux Disease (GERD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Non-Erosive GERD
Erosive GERD

7. Peptic Ulcer Market Regional And Country Analysis

7.1. Global Peptic Ulcer Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Peptic Ulcer Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Peptic Ulcer Market

8.1. Asia-Pacific Peptic Ulcer Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Peptic Ulcer Market

9.1. China Peptic Ulcer Market Overview
9.2. China Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Peptic Ulcer Market

10.1. India Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Peptic Ulcer Market

11.1. Japan Peptic Ulcer Market Overview
11.2. Japan Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Peptic Ulcer Market

12.1. Australia Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Peptic Ulcer Market

13.1. Indonesia Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Peptic Ulcer Market

14.1. South Korea Peptic Ulcer Market Overview
14.2. South Korea Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Peptic Ulcer Market

15.1. Western Europe Peptic Ulcer Market Overview
15.2. Western Europe Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Peptic Ulcer Market

16.1. UK Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Peptic Ulcer Market

17.1. Germany Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Peptic Ulcer Market

18.1. France Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Peptic Ulcer Market

19.1. Italy Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Peptic Ulcer Market

20.1. Spain Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Peptic Ulcer Market

21.1. Eastern Europe Peptic Ulcer Market Overview
21.2. Eastern Europe Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Peptic Ulcer Market

22.1. Russia Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Peptic Ulcer Market

23.1. North America Peptic Ulcer Market Overview
23.2. North America Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Peptic Ulcer Market

24.1. USA Peptic Ulcer Market Overview
24.2. USA Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Peptic Ulcer Market

25.1. Canada Peptic Ulcer Market Overview
25.2. Canada Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Peptic Ulcer Market

26.1. South America Peptic Ulcer Market Overview
26.2. South America Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Peptic Ulcer Market

27.1. Brazil Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Peptic Ulcer Market

28.1. Middle East Peptic Ulcer Market Overview
28.2. Middle East Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Peptic Ulcer Market

29.1. Africa Peptic Ulcer Market Overview
29.2. Africa Peptic Ulcer Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Peptic Ulcer Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Peptic Ulcer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Peptic Ulcer Market Competitive Landscape And Company Profiles

30.1. Peptic Ulcer Market Competitive Landscape
30.2. Peptic Ulcer Market Company Profiles
- 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Peptic Ulcer Market Other Major And Innovative Companies

31.1. Sanofi S.A
31.2. Bristol-Myers Squibb Company
31.3. AstraZeneca plc
31.4. Abbott Laboratories
31.5. GlaxoSmithKline plc
31.6. Takeda Pharmaceutical Company Limited
31.7. Eli Lilly and Company
31.8. Amgen Inc.
31.9. Teva Pharmaceutical Industries Ltd.
31.10. CSL Limited
31.11. Boehringer Ingelheim International GmbH
31.12. Eisai Co. Ltd.
31.13. Sun Pharmaceutical Industries Ltd.
31.14. Otsuka Pharmaceutical Company
31.15. Dr. Reddy's Laboratories Ltd.

32. Global Peptic Ulcer Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Peptic Ulcer Market

34. Recent Developments In The Peptic Ulcer Market

35. Peptic Ulcer Market High Potential Countries, Segments and Strategies

35.1 Peptic Ulcer Market In 2029 - Countries Offering Most New Opportunities
35.2 Peptic Ulcer Market In 2029 - Segments Offering Most New Opportunities
35.3 Peptic Ulcer Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer